Ehong Gu
Vermögen: - $ am 31.08.2026
Vermögen: - $ am 31.08.2026
Ehong Gu is currently the Chief Financial & Accounting Officer at LianBio.
Previously, she worked as the Assistant Vice President-Finance at CStone Pharmaceuticals Co. Ltd. from 2019 to 2021.
She holds an MBA from Rotman School of Management and an undergraduate degree from Shanghai University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LIANBIO -.--% | 19.12.2023 | 0 ( -.--% ) | - $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| LIANMEDICAL | Finanzdirektor/CFO | 19.12.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| CSTONE PHARMACEUTICALS | Corporate Officer/Principal | 01.01.2021 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Rotman School of Management
Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai University
Shanghai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CStone Pharmaceuticals Co. Ltd.
CStone Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatments for oncology, cardiovascular diseases, rheumatoid arthritis, hematology and autoimmune diseases | Health Technology |
LianBio
LianBio BiotechnologyHealth Technology Operates as a biotechnology company focused on bringing paradigm-shifting medicines to patients | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen